RYAHF (RYAH Group) Marketable Securities: $0.00 Mil (As of Sep. 2022)


What is RYAH Group Marketable Securities?

RYAH Group RYAHF Marketable Securities is $0.00 Mil as of Sep. 2022.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. RYAH Group's Marketable Securities for the quarter that ended in Sep. 2022 was $0.00 Mil.


RYAH Group  (OTCPK:RYAHF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


RYAH Group Marketable Securities Related Terms


RYAH Group Marketable Securities Historical Data

* Premium members only.

The historical data trend for RYAH Group's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group Marketable Securities Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Marketable Securities
0.00 0.00

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Marketable Securities Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

RYAH Group Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
RYAH Group (RYAHF) has a Marketable Securities of $0.00 Mil as of Sep. 2022. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on RYAH Group and its competitors.
Is RYAH Group's Marketable Securities too high?
RYAH Group's current Marketable Securities is $0.00 Mil.
How does RYAH Group's Marketable Securities compare to CERN and VEEV?
RYAH Group's Marketable Securities of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on RYAH Group and its competitors. RYAH Group's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Marketable Securities is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.